1481280750670516229

We are looking forward to presenting next month at the 2022 TCT Meetings. We have eight accepted abstracts covering our omidubicel and GDA-201 programs. One of our omidubicel abstracts also received TCT’s Best Abstract Award! Read more in our release: https://t.co/i07UezIUdi https://t.co/rl2puJgmDC

Send us a message